301331.SZ
恩威医药
SZSE · C 制造业 · CN
CNY 21.84
−1.31%Margins
Gross margin
51.1%
EBITDA margin
12.9%
EBIT margin
6.6%
Net margin
5.5%
FCF margin
2.8%
4.4%
Return on equity
3.2%
Return on assets
5.4%
Return on invested capital
0.58x
Asset turnover
CNY 81.4M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026